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in High Volume Quaternary Centres?
ABSTRACT
Birkmeyer, J. D., Samuel, R. G., Finlayson, M. P. H.,
Tosteson, A. N. A., Sharp, S. M., Warshaw, A. L. and
Fisher, E. S.
Background: Reports of better results at national
referral centers than at low-volume community hos-
pitals have prompted calls for regionalizing pancre-
aticoduodenectomy (the Whipple procedure). We
examined the relationship between hospital volume
and mortality with this procedure across all US
hospitals.
Methods: Using information from the Medicare
claims database, we performed a national cohort
study of 7229 Medicare patients more than 65 years
old undergoing pancreaticoduodenectomy between
1992 and 1995. We divided the study population into
approximate quartiles according to the hospital’s
average annual volume of pancreaticoduodenec-
tomies in Medicare patients: very low (<l/y), low
(1-2/y), medium (2-5/y), and high (5+/y). Using
multivariate logistic regression to account for poten-
tially confounding patient characteristics, we exam-
ined the association between institutional volume
and in-hospital mortality, our primary outcome
measure.
Results: More than 50% of Medicare patients
undergoing pancreaticoduodenectomy received care
at hospitals performing fewer than 2 such procedures
per year. In-hospital mortality rates at these low- and
very-low-volume hospitals were 3- to 4-fold higher
than at high-volume hospitals (12% and 16%, respec-
tively, vs. 4%, P<.001). Within the high-volume
quartile, the 10 hospitals with the nation’s highest
volumes had lower mortality rates than the remaining
high-volume centers (2.1% vs. 6.2%, P<.01). The
strong association between institutional volume and
mortality could not be attributed to patient case-mix
differences or referral bias.
Conclusions: Although volume-outcome relation-
ships have been reported for many complex surgical
procedures, hospital experience is particularly im-
portantwith pancreaticoduodenectomy. Patients con-
sidering this procedure should be given the option
of care at a high-volume referral center. (Surgery, 1999,
125, 250- 6.)
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ences and the Departments of Medicine and Sur-
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Junction, Vt, and the Department of Surgery, Massa-
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PAPER DISCUSSION
In the last decade a number of studies have con-
cluded that hospital volume favourably influ-
ences the results of pancreaticoduodenectomy
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and of equal importance, that low volume results
in higher mortality. The problem however is not
that simple. Some of the facts within Birkmeyer’s
study need to be re-stated. First, following pan-
creaticoduodenectomy in patients over the age of
65 in the United States the overall postoperative
mortality is 11.1%. Second, the resectability rate
for pancreatic cancer in the United States (calcu-
lated on the basis of 1800 resections per year in
patients over 65 equivalent to a total resection
rate of 3600 from a total annual incidence of
29,000 pancreatic cancers) is 12%. Third, from 4
publications the authors have quoted very
favourable 5-year survival rates ranging from
10%-25%. They have not discussed the conten-
tious paper by Gudjonsson that dealt with
survival rates after resection for carcinoma of
the pancreas. Gudjonsson standardised and
compared results reported in 340 publications
and reported that the best overall 5-year survival
rate in a surgical series was only 3.6% [1].
Contrary to the authors suggestion that only
State-level studies have been performed pre-
viously in analysis of pancreaticoduodenectomy
results, a number of national and international
surveys can be found in the literature. Glazer
and colleagues analysed 28 series and a total of
2,172 patients undergoing pancreatic resection
and found 150 deaths (6.9%) with a median
mortality of 7.5% and an interquartile range of
4.5%- 12% [2, 3]. Janes and colleagues on behalf
of the commission on cancer of the American
College of Surgeons, conducted a large national
survey to assess methods of diagnosis, staging,
treatment and outcome of patients with adeno-
carcinoma of the pancreas: in two study periods
involving 987 institutions and nearly 17,000
cases, they reported a lOwer operative mortality
in units performing more than 20 cases per
year [4]. Neoptolemos and colleagues on behalf
of the UK Pancreatic Cancer Group analysed
1,026 resections of pancreatic and periampul-
lary tumours in institutions performing 5-7 re-
sections per year and revealed an operative
mortality of 5% [5]. Finally, a recent publication
by Simunovic and colleagues, who investigated
postoperative mortality after pancreatic resec-
tion in Canadian publicly funded hospitals, re-
ported a 3.4% mortality in high volume hospitals
i.e., those performing more than 42 resections in
the 6-year period of the study [6], compared
with a 14.4% mortality in low volume hospitals.
Such international and national surveys ap-
pear to reinforce the high volume: low mortality
message. However, another important publica-
tion has been omitted from the authors argu-
ment, which is the paper by Wade and
colleagues relating to the treatment of periam-
pullary cancer in the US Department of Defence
hospitals [7]. In this study the 30-day operative
mortality rate was 8.5% and was equivalent in
both teaching hospitals and smaller community
type institutions. The highest volume hospital
performed 3-4 resections per year and had
similar mortality rates to smaller institutions
performing fewer resections. The authors of
this paper argued that the even distribution
of mortality was due to the lack of financial
and logistic barriers in the smaller hospitals,
which enabled them to maintain facilities and
staffing to a comparable standard in both the
larger teaching hospitals and the smaller com-
munity hospitals. This argument has been ad-
dressed briefly by Berkmeyer and colleagues but
discounted because they believe that quality
improvements in hospitals performing low
numbers of pancreaticoduodenectomies per
year would be inefficient and impossible to
evaluate at the local level. Such an attitude
would impoverish smaller hospitals at the
expense of larger institutions and further impair
the ability of small hospitals to perform quality
surgery. Also, at what point are the "under-
performing" hospitals eliminated from practis-
ing complex surgery? And how many times will
the cycle be repeated until all complex surgery is
performed in super-institutions? Moreover it
has been demonstrated that once a quality
service has been established by investment in
capital and personnel, the cost to the health careHPB INTERNATIONAL 361
system of performing each pancreaticoduode-
nectomy diminishes because morbidity and
mortality is lowered [8, 9]. Or, put more simply
in order to save money (and lives) capital
investment must be made, not only in equip-
ment but also in personnel and training.
Patterns of work may also be important. Con-
sidering hospital volume, the high volume
hospitals will have a larger number of surgeons
performing pancreaticoduodenectomies and
therefore the number of cases per surgeon may
be similar to the cases per surgeon in the smaller
hospitals. In the larger institutions, 2 specialist
surgeons probably work together performing a
6- 8 hour pancreaticoduodenectomy operation
and therefore, may be able to eliminate errors
due to fatigue and inattention. Thus an invest-
ment in teams of surgeons that are available to
work together in the operating room and in the
pre- and postoperative care of the patient in con-
juction with a team of gastroenterologists, radio-
logists and intensivists is probably the correct
path to follow to reduce mortality. In practical
terms, there may be a compromise between the
wishes of the patient to stay near to their home
for their major surgery and the health care
planners who will see the need to have low
mortality in a quality environment.
An imaginative means of upgrading quality
in smaller hospitals by the use of Telemedicine
is suggested by Birkmeyer and colleagues. This
solution readily lends itself to radiology but is
less practical for the surgeon on the spot or the
intensivist faced with a rapidly deteriorating
patient in the early postoperative period. More
power could be put in the hands of the patients
by publishing pancreaticoduodenectomy mor-
tality rates by institution which would enable
the public to "vote with their feet" and encourage
hospitals with high mortality to make the
necessary investments to improve their results.
Analysis of surgical outcome is complex and
is rarely dependent on one variable; we need to
investigate the results of pancreaticoduodenect-
omy by more than hospital volume alone [10].
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